Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |